{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:27:14Z","timestamp":1792783634991,"version":"4.5.0"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:00:00Z","timestamp":1791849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:00:00Z","timestamp":1791849600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Medical University of Lodz Grant","award":["503\/0\u2013078\u201304\/503\u201301\u2013001"],"award-info":[{"award-number":["503\/0\u2013078\u201304\/503\u201301\u2013001"]}],"id":[{"id":"https:\/\/ror.org\/02t4ekc95","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharmacol. Rep"],"DOI":"10.1007\/s43440-026-00915-w","type":"journal-article","created":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T08:11:06Z","timestamp":1791879066000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Dexamethasone-mediated modulation of the renin-angiotensin system: current insights"],"prefix":"10.1007","author":[{"given":"Katarzyna","family":"Gajewska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Wosiak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasza","family":"Wiertek-P\u0142oszaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weronika","family":"Broszkiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7501-8369","authenticated-orcid":false,"given":"Kamila","family":"Domi\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,13]]},"reference":[{"key":"915_CR1","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/S0031-6997(24)01458-3","volume":"52","author":"M de Gasparo","year":"2000","unstructured":"de Gasparo M, Catt KJ, Inagami T, Wright JW, Unger T. International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev. 2000;52:415\u201372. https:\/\/doi.org\/10.1016\/S0031-6997(24)01458-3.","journal-title":"Pharmacol Rev"},{"key":"915_CR2","doi-asserted-by":"publisher","first-page":"4993","DOI":"10.2741\/3058","volume":"13","author":"G Wolf","year":"2008","unstructured":"Wolf G. Novel aspects of the renin-angiotensin-aldosterone system. Front Biosci. 2008;13:4993\u20135005. https:\/\/doi.org\/10.2741\/3058.","journal-title":"Front Biosci"},{"key":"915_CR3","doi-asserted-by":"publisher","first-page":"777","DOI":"10.3390\/vetsci12080777","volume":"12","author":"A Valentini","year":"2025","unstructured":"Valentini A, Heilmann RM, K\u00fchne A, Biagini L, De Bellis D, Rossi G. The renin-angiotensin-aldosterone system (RAAS): beyond cardiovascular regulation. Vet Sci. 2025;12:777. https:\/\/doi.org\/10.3390\/vetsci12080777.","journal-title":"Vet Sci"},{"key":"915_CR4","doi-asserted-by":"publisher","first-page":"3038","DOI":"10.1210\/en.2015-1197","volume":"156","author":"AJ Forhead","year":"2015","unstructured":"Forhead AJ, Jellyman JK, De Blasio MJ, Johnson E, Giussani DA, Broughton Pipkin F, et al. Maternal dexamethasone treatment alters tissue and circulating components of the renin-angiotensin system in the pregnant ewe and fetus. Endocrinology. 2015;156:3038\u201346. https:\/\/doi.org\/10.1210\/en.2015-1197.","journal-title":"Endocrinology"},{"key":"915_CR5","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/0960-0760(93)90119-h","volume":"45","author":"E Hackenthal","year":"1993","unstructured":"Hackenthal E, Klett C. Angiotensin II and dexamethasone regulate angiotensinogen mRNA by different mechanisms. J Steroid Biochem Mol Biol. 1993;45:33\u201340. https:\/\/doi.org\/10.1016\/0960-0760(93)90119-h.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"915_CR6","doi-asserted-by":"publisher","first-page":"37564","DOI":"10.1039\/D0RA05474G","volume":"10","author":"KK Dey","year":"2020","unstructured":"Dey KK, Ghosh M. Understanding the structure and dynamics of anti-inflammatory corticosteroid dexamethasone by solid-state NMR spectroscopy. RSC Adv. 2020;10:37564\u201375. https:\/\/doi.org\/10.1039\/D0RA05474G.","journal-title":"RSC Adv"},{"key":"915_CR7","doi-asserted-by":"publisher","first-page":"2936","DOI":"10.1002\/jps.21222","volume":"97","author":"M Katz","year":"2008","unstructured":"Katz M, Gans EH. Topical corticosteroids, structure-activity and the glucocorticoid receptor: discovery and development\u2014a process of planned serendipity. J Pharm Sci. 2008;97:2936\u201347. https:\/\/doi.org\/10.1002\/jps.21222.","journal-title":"J Pharm Sci"},{"key":"915_CR8","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1210\/endrev\/bnae008","volume":"45","author":"J Lockett","year":"2024","unstructured":"Lockett J, Inder WJ, Clifton VL. The glucocorticoid receptor: isoforms, functions, and contribution to glucocorticoid sensitivity. Endocr Rev. 2024;45:593\u2013624. https:\/\/doi.org\/10.1210\/endrev\/bnae008.","journal-title":"Endocr Rev"},{"key":"915_CR9","doi-asserted-by":"publisher","first-page":"61","DOI":"10.2165\/00003088-200544010-00003","volume":"44","author":"D Czock","year":"2005","unstructured":"Czock D, Keller F, Rasche FM, H\u00e4ussler U. Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids. Clin Pharmacokinet. 2005;44:61\u201398. https:\/\/doi.org\/10.2165\/00003088-200544010-00003.","journal-title":"Clin Pharmacokinet"},{"key":"915_CR10","doi-asserted-by":"publisher","first-page":"7120","DOI":"10.3390\/jcm12227120","volume":"12","author":"V Bourdin","year":"2023","unstructured":"Bourdin V, Bigot W, Vanjak A, Burlacu R, Lopes A, Champion K, et al. Dexamethasone drug-drug interactions: a clinical perspective. J Clin Med. 2023;12:7120. https:\/\/doi.org\/10.3390\/jcm12227120.","journal-title":"J Clin Med"},{"key":"915_CR11","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.3389\/fimmu.2019.01744","volume":"10","author":"C Strehl","year":"2019","unstructured":"Strehl C, Ehlers L, Gaber T, Buttgereit F. Glucocorticoids\u2014all-rounders tackling the versatile players of the immune system. Front Immunol. 2019;10:1744. https:\/\/doi.org\/10.3389\/fimmu.2019.01744.","journal-title":"Front Immunol"},{"key":"915_CR12","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1042\/cs0940557","volume":"94","author":"PJ Barnes","year":"1998","unstructured":"Barnes PJ. Anti-inflammatory actions of glucocorticoids: molecular mechanisms. Clin Sci (Lond). 1998;94:557\u201372. https:\/\/doi.org\/10.1042\/cs0940557.","journal-title":"Clin Sci (Lond)"},{"key":"915_CR13","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/ar398","volume":"4","author":"J Saklatvala","year":"2002","unstructured":"Saklatvala J. Glucocorticoids: do we know how they work? Arthritis Res. 2002;4:146\u201350. https:\/\/doi.org\/10.1186\/ar398.","journal-title":"Arthritis Res"},{"key":"915_CR14","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/s0006-3223(02)01480-4","volume":"52","author":"PW Gold","year":"2002","unstructured":"Gold PW, Drevets WC, Charney DS. New insights into the role of cortisol and the glucocorticoid receptor in severe depression. Biol Psychiatry. 2002;52:381\u20135. https:\/\/doi.org\/10.1016\/s0006-3223(02)01480-4.","journal-title":"Biol Psychiatry"},{"key":"915_CR15","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.endinu.2021.05.012","volume":"69","author":"RA Vargas Vargas","year":"2022","unstructured":"Vargas Vargas RA, Varela Mill\u00e1n JM, Fajardo Bonilla E. Renin-angiotensin system: basic and clinical aspects\u2014a general perspective. Endocrinol Diabetes Nutr. 2022;69:52\u201362. https:\/\/doi.org\/10.1016\/j.endinu.2021.05.012.","journal-title":"Endocrinol Diabetes Nutr"},{"key":"915_CR16","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.3390\/cancers18121998","volume":"18","author":"W Broszkiewicz","year":"2026","unstructured":"Broszkiewicz W, Wiertek-P\u0142oszaj N, Gajewska K, Wosiak A, Domi\u0144ska K. Dexamethasone as a modulator of renin-angiotensin system receptor expression in prostate and ovarian cancer cells under standard and low-serum conditions. Cancers (Basel). 2026;18:1998. https:\/\/doi.org\/10.3390\/cancers18121998.","journal-title":"Cancers (Basel)"},{"key":"915_CR17","unstructured":"Kaur J, Rout P. Physiology, renin angiotensin system. In: statpearls. Treasure Island (FL): statpearls Publishing. 2026. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK470410\/."},{"issue":"5","key":"915_CR18","doi-asserted-by":"publisher","first-page":"H958","DOI":"10.1152\/ajpheart.00723.2018","volume":"316","author":"RAS Santos","year":"2019","unstructured":"Santos RAS, Oudit GY, Verano-Braga T, Canta G, Steckelings UM, Bader M. The renin-angiotensin system: going beyond the classical paradigms. Am J Physiol Heart Circ Physiol. 2019;316(5):H958\u201370. https:\/\/doi.org\/10.1152\/ajpheart.00723.2018.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"915_CR19","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1042\/CS20120089","volume":"123","author":"R Kumar","year":"2012","unstructured":"Kumar R, Thomas CM, Yong QC, Chen W, Baker KM. The intracrine renin-angiotensin system. Clin Sci (Lond). 2012;123:273\u201384. https:\/\/doi.org\/10.1042\/CS20120089.","journal-title":"Clin Sci (Lond)"},{"key":"915_CR20","doi-asserted-by":"publisher","first-page":"111","DOI":"10.4172\/jcs.1000111","volume":"1","author":"KD Singh","year":"2016","unstructured":"Singh KD, Karnik SS. Angiotensin receptors: structure, function, signaling and clinical applications. J Cell Signal. 2016;1:111. https:\/\/doi.org\/10.4172\/jcs.1000111.","journal-title":"J Cell Signal"},{"key":"915_CR21","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1186\/s12935-023-03080-9","volume":"23","author":"B Hassani","year":"2023","unstructured":"Hassani B, Attar Z, Firouzabadi N. The renin-angiotensin-aldosterone system (RAAS) signaling pathways and cancer: foes versus allies. Cancer Cell Int. 2023;23:254. https:\/\/doi.org\/10.1186\/s12935-023-03080-9.","journal-title":"Cancer Cell Int"},{"key":"915_CR22","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.rdc.2015.08.002","volume":"42","author":"S Ramamoorthy","year":"2016","unstructured":"Ramamoorthy S, Cidlowski JA. Corticosteroids: mechanisms of action in health and disease. Rheum Dis Clin North Am. 2016;42:15\u201331. https:\/\/doi.org\/10.1016\/j.rdc.2015.08.002.","journal-title":"Rheum Dis Clin North Am"},{"key":"915_CR23","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1111\/bcpt.13995","volume":"134","author":"T Lehtola","year":"2024","unstructured":"Lehtola T, Nummenmaa E, Nieminen R, H\u00e4m\u00e4l\u00e4inen M, Vuolteenaho K, Moilanen E. The glucocorticoid dexamethasone alleviates allergic inflammation through a mitogen-activated protein kinase phosphatase-1-dependent mechanism in mice. Basic Clin Pharmacol Toxicol. 2024;134:686\u201394. https:\/\/doi.org\/10.1111\/bcpt.13995.","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"915_CR24","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1113\/jphysiol.2013.267609","volume":"592","author":"RW Hunter","year":"2014","unstructured":"Hunter RW, Ivy JR, Bailey MA. Glucocorticoids and renal Na\u207a transport: implications for hypertension and salt sensitivity. J Physiol. 2014;592:1731\u201344. https:\/\/doi.org\/10.1113\/jphysiol.2013.267609.","journal-title":"J Physiol"},{"key":"915_CR25","doi-asserted-by":"publisher","first-page":"e14105","DOI":"10.14814\/phy2.14105","volume":"7","author":"D Stoll","year":"2019","unstructured":"Stoll D, Yokota R, Sanches Arag\u00e3o D, Casarini DE. Both aldosterone and spironolactone can modulate the intracellular ACE\/ANG II\/AT1 and ACE2\/ANG (1\u20137)\/MAS receptor axes in human mesangial cells. Physiol Rep. 2019;7:e14105. https:\/\/doi.org\/10.14814\/phy2.14105.","journal-title":"Physiol Rep"},{"key":"915_CR26","doi-asserted-by":"publisher","first-page":"5749","DOI":"10.1074\/jbc.M114.601922","volume":"290","author":"VG Pandey","year":"2015","unstructured":"Pandey VG, Jain S, Rana A, Puri N, Arudra SKC, Mopidevi B, et al. Dexamethasone promotes hypertension by allele-specific regulation of the human angiotensinogen gene. J Biol Chem. 2015;290:5749\u201358. https:\/\/doi.org\/10.1074\/jbc.M114.601922.","journal-title":"J Biol Chem"},{"key":"915_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2174\/1570161043476483","volume":"2","author":"S Yang","year":"2004","unstructured":"Yang S, Zhang L. Glucocorticoids and vascular reactivity. Curr Vasc Pharmacol. 2004;2:1\u201312. https:\/\/doi.org\/10.2174\/1570161043476483.","journal-title":"Curr Vasc Pharmacol"},{"key":"915_CR28","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/j.kjms.2016.09.007","volume":"32","author":"C Liu","year":"2016","unstructured":"Liu C, Ge N, Zhai JL, Zhang JX. Dexamethasone-induced diuresis is associated with inhibition of the renin-angiotensin-aldosterone system in rats. Kaohsiung J Med Sci. 2016;32:614\u201319. https:\/\/doi.org\/10.1016\/j.kjms.2016.09.007.","journal-title":"Kaohsiung J Med Sci"},{"key":"915_CR29","doi-asserted-by":"publisher","first-page":"3202","DOI":"10.1210\/jc.2004-2379","volume":"90","author":"DJ Brotman","year":"2005","unstructured":"Brotman DJ, Girod JP, Garcia MJ, Patel JV, Gupta M, Posch A, et al. Effects of short-term glucocorticoids on cardiovascular biomarkers. J Clin Endocrinol Metab. 2005;90:3202\u20138. https:\/\/doi.org\/10.1210\/jc.2004-2379.","journal-title":"J Clin Endocrinol Metab"},{"key":"915_CR30","doi-asserted-by":"publisher","first-page":"R1444","DOI":"10.1152\/ajpregu.00294.2007","volume":"293","author":"RL Thunhorst","year":"2007","unstructured":"Thunhorst RL, Beltz TG, Johnson AK. Glucocorticoids increase salt appetite by promoting water and sodium excretion. Am J Physiol Regul Integr Comp Physiol. 2007;293:R1444\u201351. https:\/\/doi.org\/10.1152\/ajpregu.00294.2007.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"915_CR31","doi-asserted-by":"publisher","first-page":"14007","DOI":"10.3390\/ijms241814007","volume":"24","author":"TL Lu","year":"2023","unstructured":"Lu TL, Wu SN. Investigating the impact of selective modulators on the renin-angiotensin-aldosterone system: unraveling their off-target perturbations of transmembrane ionic currents. Int J Mol Sci. 2023;24:14007. https:\/\/doi.org\/10.3390\/ijms241814007.","journal-title":"Int J Mol Sci"},{"key":"915_CR32","doi-asserted-by":"publisher","first-page":"1430334","DOI":"10.3389\/fendo.2024.1430334","volume":"15","author":"C Zhao","year":"2024","unstructured":"Zhao C, He L, Li L, Deng F, Zhang M, Wang C, et al. Prenatal glucocorticoids exposure and adverse cardiovascular effects in offspring. Front Endocrinol (Lausanne). 2024;15:1430334. https:\/\/doi.org\/10.3389\/fendo.2024.1430334.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"915_CR33","doi-asserted-by":"publisher","first-page":"4455","DOI":"10.1210\/en.2002-220534","volume":"143","author":"KM Moritz","year":"2002","unstructured":"Moritz KM, Johnson K, Douglas-Denton R, Wintour EM, Dodic M. Maternal glucocorticoid treatment programs alterations in the renin-angiotensin system of the ovine fetal kidney. Endocrinology. 2002;143:4455\u201363. https:\/\/doi.org\/10.1210\/en.2002-220534.","journal-title":"Endocrinology"},{"key":"915_CR34","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1113\/jphysiol.2006.125773","volume":"579","author":"RR Singh","year":"2007","unstructured":"Singh RR, Cullen-McEwen LA, Kett MM, Boon WM, Dowling J, Bertram JF, et al. Prenatal corticosterone exposure results in altered AT1\/AT2, nephron deficit and hypertension in the rat offspring. J Physiol. 2007;579:503\u201313. https:\/\/doi.org\/10.1113\/jphysiol.2006.125773.","journal-title":"J Physiol"},{"key":"915_CR35","doi-asserted-by":"publisher","first-page":"18755","DOI":"10.1038\/s41598-020-75652-y","volume":"10","author":"S Tharmalingam","year":"2020","unstructured":"Tharmalingam S, Khurana S, Murray A, Lamothe J, Tai TC. Whole transcriptome analysis of adrenal glands from prenatal glucocorticoid programmed hypertensive rodents. Sci Rep. 2020;10:18755. https:\/\/doi.org\/10.1038\/s41598-020-75652-y.","journal-title":"Sci Rep"},{"key":"915_CR36","doi-asserted-by":"publisher","first-page":"R80","DOI":"10.1152\/ajpregu.00421.2003","volume":"286","author":"RD Roghair","year":"2004","unstructured":"Roghair RD, Lamb FS, Bedell KA, Smith OM, Scholz TD, Segar JL. Late-gestation betamethasone enhances coronary artery responsiveness to angiotensin II in fetal sheep. Am J Physiol Regul Integr Comp Physiol. 2004;286:R80\u20138. https:\/\/doi.org\/10.1152\/ajpregu.00421.2003.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"915_CR37","doi-asserted-by":"publisher","first-page":"e106827","DOI":"10.1371\/journal.pone.0106827","volume":"9","author":"Q Xue","year":"2014","unstructured":"Xue Q, Patterson AJ, Xiao D, Zhang L. Glucocorticoid modulates angiotensin II receptor expression patterns and protects the heart from ischemia and reperfusion injury. PLoS ONE. 2014;9:e106827. https:\/\/doi.org\/10.1371\/journal.pone.0106827.","journal-title":"PLoS ONE"},{"key":"915_CR38","doi-asserted-by":"publisher","first-page":"H836","DOI":"10.1152\/ajpheart.2000.279.2.H836","volume":"279","author":"G Valen","year":"2000","unstructured":"Valen G, Kawakami T, T\u00e4hep\u00f5ld P, Dumitrescu A, L\u00f6wbeer C, Vaage J. Glucocorticoid pretreatment protects cardiac function and induces cardiac heat shock protein 72. Am J Physiol Heart Circ Physiol. 2000;279:H836\u201343. https:\/\/doi.org\/10.1152\/ajpheart.2000.279.2.H836.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"915_CR39","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1016\/j.lfs.2004.04.031","volume":"75","author":"E Varga","year":"2004","unstructured":"Varga E, Nagy N, L\u00e1z\u00e1r J, Czifra G, Bak I, B\u00edr\u00f3 T, et al. Inhibition of ischemia\/reperfusion-induced damage by dexamethasone in isolated working rat hearts: the role of cytochrome c release. Life Sci. 2004;75:2411\u201323. https:\/\/doi.org\/10.1016\/j.lfs.2004.04.031.","journal-title":"Life Sci"},{"key":"915_CR40","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1016\/j.lfs.2009.03.014","volume":"84","author":"WJ Fan","year":"2009","unstructured":"Fan WJ, Genade S, Genis A, Huisamen B, Lochner A. Dexamethasone-induced cardioprotection: a role for the phosphatase MKP-1? Life Sci. 2009;84:838\u201346. https:\/\/doi.org\/10.1016\/j.lfs.2009.03.014.","journal-title":"Life Sci"},{"key":"915_CR41","doi-asserted-by":"publisher","first-page":"3087","DOI":"10.1161\/01.cir.94.12.3087","volume":"94","author":"WR Ford","year":"1996","unstructured":"Ford WR, Clanachan AS, Jugdutt BI. Opposite effects of angiotensin AT1 and AT2 receptor antagonists on recovery of mechanical function after ischemia-reperfusion in isolated working rat hearts. Circulation. 1996;94:3087\u20139. https:\/\/doi.org\/10.1161\/01.cir.94.12.3087.","journal-title":"Circulation"},{"key":"915_CR42","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.drudis.2010.11.016","volume":"16","author":"C Dasgupta","year":"2011","unstructured":"Dasgupta C, Zhang L. Angiotensin II receptors and drug discovery in cardiovascular disease. Drug Discov Today. 2011;16:22\u201334. https:\/\/doi.org\/10.1016\/j.drudis.2010.11.016.","journal-title":"Drug Discov Today"},{"key":"915_CR43","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.jash.2018.06.004","volume":"12","author":"F Duchatsch","year":"2018","unstructured":"Duchatsch F, Constantino PB, Herrera NA, Fabr\u00edcio MF, Tardelli LP, Martuscelli AM, et al. Short-term exposure to dexamethasone promotes autonomic imbalance to the heart before hypertension. J Am Soc Hypertens. 2018;12:605\u201313. https:\/\/doi.org\/10.1016\/j.jash.2018.06.004.","journal-title":"J Am Soc Hypertens"},{"issue":"Suppl 3","key":"915_CR44","doi-asserted-by":"publisher","first-page":"U49","DOI":"10.1530\/eje.0.151u049","volume":"151","author":"JR Seckl","year":"2004","unstructured":"Seckl JR. Prenatal glucocorticoids and long-term programming. Eur J Endocrinol. 2004;151(Suppl 3):U49\u201362. https:\/\/doi.org\/10.1530\/eje.0.151u049.","journal-title":"Eur J Endocrinol"},{"key":"915_CR45","doi-asserted-by":"publisher","first-page":"e011484","DOI":"10.1161\/JAHA.118.011484","volume":"8","author":"E Severinova","year":"2019","unstructured":"Severinova E, Alikunju S, Deng W, Dhawan P, Sayed N, Sayed D. Glucocorticoid receptor-binding and transcriptome signature in cardiomyocytes. J Am Heart Assoc. 2019;8:e011484. https:\/\/doi.org\/10.1161\/JAHA.118.011484.","journal-title":"J Am Heart Assoc"},{"key":"915_CR46","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s11010-015-2586-9","volume":"411","author":"KN Sangeetha","year":"2016","unstructured":"Sangeetha KN, Lakshmi BS, Devaraj SN. Dexamethasone promotes hypertrophy of H9C2 cardiomyocytes through calcineurin B pathway, independent of NFAT activation. Mol Cell Biochem. 2016;411:241\u201352. https:\/\/doi.org\/10.1007\/s11010-015-2586-9.","journal-title":"Mol Cell Biochem"},{"key":"915_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000227803","volume":"24","author":"SG Roy","year":"2009","unstructured":"Roy SG, De P, Mukherjee D, Chander V, Konar A, Bandyopadhyay D, et al. Excess of glucocorticoid induces cardiac dysfunction via activating angiotensin II pathway. Cell Physiol Biochem. 2009;24:1\u201310. https:\/\/doi.org\/10.1159\/000227803.","journal-title":"Cell Physiol Biochem"},{"key":"915_CR48","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1530\/JOE-10-0431","volume":"209","author":"P De","year":"2011","unstructured":"De P, Ghose Roy S, Kar D, Bandyopadhyay A. Excess of glucocorticoid induces myocardial remodeling and alteration of calcium signaling in cardiomyocytes. J Endocrinol. 2011;209:105\u201314. https:\/\/doi.org\/10.1530\/JOE-10-0431.","journal-title":"J Endocrinol"},{"key":"915_CR49","doi-asserted-by":"publisher","first-page":"101536","DOI":"10.1016\/j.redox.2020.101536","volume":"34","author":"D Kra\u010dun","year":"2020","unstructured":"Kra\u010dun D, Klop M, Knirsch A, Petry A, Kanchev I, Chalupsky K, et al. NADPH oxidases and HIF1 promote cardiac dysfunction and pulmonary hypertension in response to glucocorticoid excess. Redox Biol. 2020;34:101536. https:\/\/doi.org\/10.1016\/j.redox.2020.101536.","journal-title":"Redox Biol"},{"key":"915_CR50","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1161\/hh1901.097086","volume":"89","author":"M Dodic","year":"2001","unstructured":"Dodic M, Samuel C, Moritz K, Wintour EM, Morgan J, Grigg L, et al. Impaired cardiac functional reserve and left ventricular hypertrophy in adult sheep after prenatal dexamethasone exposure. Circ Res. 2001;89:623\u20139. https:\/\/doi.org\/10.1161\/hh1901.097086.","journal-title":"Circ Res"},{"key":"915_CR51","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1002\/tera.1420470203","volume":"47","author":"X Bian","year":"1993","unstructured":"Bian X, Seidler FJ, Slotkin TA. Fetal dexamethasone exposure interferes with establishment of cardiac noradrenergic innervation and sympathetic activity. Teratology. 1993;47:109\u201317. https:\/\/doi.org\/10.1002\/tera.1420470203.","journal-title":"Teratology"},{"key":"915_CR52","doi-asserted-by":"publisher","first-page":"H209","DOI":"10.1152\/ajpheart.00075.2024","volume":"328","author":"L Madhavpeddi","year":"2025","unstructured":"Madhavpeddi L, Martinez M, Alvarez J, Sharma A, Hu C, Tobet SA. Prenatal dexamethasone programs autonomic dysregulation in female rats. Am J Physiol Heart Circ Physiol. 2025;328:H209\u201320. https:\/\/doi.org\/10.1152\/ajpheart.00075.2024.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"915_CR53","doi-asserted-by":"publisher","first-page":"e69149","DOI":"10.1371\/journal.pone.0069149","volume":"8","author":"L O\u2019Sullivan","year":"2013","unstructured":"O\u2019Sullivan L, Cuffe JSM, Paravicini TM, Campbell S, Dickinson H, Singh RR, et al. Prenatal exposure to dexamethasone in the mouse alters cardiac growth patterns and increases pulse pressure in aged male offspring. PLoS ONE. 2013;8:e69149. https:\/\/doi.org\/10.1371\/journal.pone.0069149.","journal-title":"PLoS ONE"},{"key":"915_CR54","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1530\/JOE-18-0666","volume":"241","author":"EJ Agnew","year":"2019","unstructured":"Agnew EJ, Garcia-Burgos A, Richardson RV, Manos H, Thomson AJW, Sooy K, et al. Antenatal dexamethasone treatment transiently alters diastolic function in the mouse fetal heart. J Endocrinol. 2019;241:279\u201392. https:\/\/doi.org\/10.1530\/JOE-18-0666.","journal-title":"J Endocrinol"},{"key":"915_CR55","doi-asserted-by":"publisher","first-page":"R646","DOI":"10.1152\/ajpregu.2001.280.3.R646","volume":"280","author":"JL Segar","year":"2001","unstructured":"Segar JL, Bedell KA, Smith OJ. Glucocorticoid modulation of cardiovascular and autonomic function in preterm lambs: role of ANG II. Am J Physiol Regul Integr Comp Physiol. 2001;280:R646\u201354. https:\/\/doi.org\/10.1152\/ajpregu.2001.280.3.R646.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"915_CR56","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.cytogfr.2023.03.002","volume":"70","author":"M Chen","year":"2023","unstructured":"Chen M, Fu W, Xu H, Liu CJ. Pathogenic mechanisms of glucocorticoid-induced osteoporosis. Cytokine Growth Factor Rev. 2023;70:54\u201366. https:\/\/doi.org\/10.1016\/j.cytogfr.2023.03.002.","journal-title":"Cytokine Growth Factor Rev"},{"key":"915_CR57","doi-asserted-by":"publisher","first-page":"835720","DOI":"10.3389\/fendo.2022.835720","volume":"13","author":"M Gado","year":"2022","unstructured":"[57]Gado M, Baschant U, Hofbauer LC, Henneicke H. Bad to the bone: the effects of therapeutic glucocorticoids on osteoblasts and osteocytes. Front Endocrinol (Lausanne). 2022;13:835720. https:\/\/doi.org\/10.3389\/fendo.2022.835720.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"915_CR58","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1007\/s12020-014-0196-z","volume":"47","author":"Y Zhang","year":"2014","unstructured":"Zhang Y, Wang K, Zheng J, Shan H, Kou J, Liu R, et al. Glucocorticoids activate the local renin-angiotensin system in bone: possible mechanism for glucocorticoid-induced osteoporosis. Endocrine. 2014;47:598\u2013608. https:\/\/doi.org\/10.1007\/s12020-014-0196-z.","journal-title":"Endocrine"},{"key":"915_CR59","doi-asserted-by":"publisher","first-page":"932691","DOI":"10.1155\/2013\/932691","volume":"2013","author":"Y Gebru","year":"2013","unstructured":"Gebru Y, Diao TY, Pan H, Mukwaya E, Zhang Y. Potential of RAS inhibition to improve metabolic bone disorders. Biomed Res Int. 2013;2013:932691. https:\/\/doi.org\/10.1155\/2013\/932691.","journal-title":"Biomed Res Int"},{"key":"915_CR60","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1007\/s00774-020-01132-y","volume":"38","author":"C Mo","year":"2020","unstructured":"Mo C, Ke J, Zhao D, Zhang B. Role of the renin\u2013angiotensin\u2013aldosterone system in bone metabolism. J Bone Min Metab. 2020;38:772\u20139. https:\/\/doi.org\/10.1007\/s00774-020-01132-y.","journal-title":"J Bone Min Metab"},{"key":"915_CR61","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.ecl.2012.04.004","volume":"41","author":"RS Weinstein","year":"2012","unstructured":"Weinstein RS. Glucocorticoid-induced osteoporosis and osteonecrosis. Endocrinol Metab Clin North Am. 2012;41:595\u2013611. https:\/\/doi.org\/10.1016\/j.ecl.2012.04.004.","journal-title":"Endocrinol Metab Clin North Am"},{"key":"915_CR62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.taap.2018.11.003","volume":"363","author":"Y Wen","year":"2019","unstructured":"Wen Y, Shangguan Y, Pan Z, Hu H, Magdalou J, Chen L, et al. Activation of local bone RAS by maternal excessive glucocorticoid participated in the fetal programming of adult osteopenia induced by prenatal caffeine exposure. Toxicol Appl Pharmacol. 2019;363:1\u201310. https:\/\/doi.org\/10.1016\/j.taap.2018.11.003.","journal-title":"Toxicol Appl Pharmacol"},{"key":"915_CR63","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1111\/j.1445-5994.1981.tb04623.x","volume":"11","author":"KA Black","year":"1981","unstructured":"Black KA, Khangure MS, Owen ET, Aust. N Z J Med. 1981;11:521\u20135. https:\/\/doi.org\/10.1111\/j.1445-5994.1981.tb04623.x.","journal-title":"N Z J Med"},{"key":"915_CR64","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.3324\/haematol.12956","volume":"93","author":"ML te Winkel","year":"2008","unstructured":"te Winkel ML, Appel IM, Pieters R, van den Heuvel-Eibrink MM. Impaired dexamethasone-related increase of anticoagulants is associated with the development of osteonecrosis in childhood acute lymphoblastic leukemia. Haematologica. 2008;93:1570\u20134. https:\/\/doi.org\/10.3324\/haematol.12956.","journal-title":"Haematologica"},{"key":"915_CR65","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1182\/blood.V112.11.898.898","volume":"112","author":"LA Mattano Jr","year":"2008","unstructured":"Mattano LA Jr, Nachman JB, Devidas M, Winick N, Raetz E, Carroll WL, et al. Increased incidence of osteonecrosis (ON) with a dexamethasone (DEX) induction for high risk acute lymphoblastic leukemia (HR-ALL): a report from the Children\u2019s Oncology Group (COG). Blood. 2008;112:898. https:\/\/doi.org\/10.1182\/blood.V112.11.898.898.","journal-title":"Blood"},{"key":"915_CR66","doi-asserted-by":"publisher","first-page":"e832","DOI":"10.1038\/cddis.2013.348","volume":"4","author":"J Li","year":"2013","unstructured":"Li J, Zhang N, Huang X, Xu J, Fernandes JC, Dai K, et al. Dexamethasone shifts bone marrow stromal cells from osteoblasts to adipocytes by C\/EBP\u03b1 promoter methylation. Cell Death Dis. 2013;4:e832. https:\/\/doi.org\/10.1038\/cddis.2013.348.","journal-title":"Cell Death Dis"},{"key":"915_CR67","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s12020-011-9580-0","volume":"41","author":"RS Weinstein","year":"2012","unstructured":"Weinstein RS. Glucocorticoid-induced osteonecrosis. Endocrine. 2012;41:183\u201390. https:\/\/doi.org\/10.1007\/s12020-011-9580-0.","journal-title":"Endocrine"},{"key":"915_CR68","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.biopha.2018.11.103","volume":"110","author":"S Deng","year":"2019","unstructured":"Deng S, Dai G, Chen S, Nie Z, Zhou J, Fang H, et al. Dexamethasone induces osteoblast apoptosis through ROS-PI3K\/AKT\/GSK3\u03b2 signaling pathway. Biomed Pharmacother. 2019;110:602\u20138. https:\/\/doi.org\/10.1016\/j.biopha.2018.11.103.","journal-title":"Biomed Pharmacother"},{"key":"915_CR69","doi-asserted-by":"publisher","first-page":"e0308557","DOI":"10.1371\/journal.pone.0308557","volume":"19","author":"Z Zhan","year":"2024","unstructured":"Zhan Z, Lian Z, Bai H. Dexamethasone inhibited angiotensin II and its receptors to reduce sepsis-induced lung and kidney injury in rats. PLoS ONE. 2024;19:e0308557. https:\/\/doi.org\/10.1371\/journal.pone.0308557.","journal-title":"PLoS ONE"},{"key":"915_CR70","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1055\/a-2372-3632","volume":"79","author":"GS Ulrich-Merzenich","year":"2025","unstructured":"Ulrich-Merzenich GS, Shcherbakova A, Pizarro C, Skowasch D. Dexamethasone, remdesivir and azithromycin modulate ACE2 and IL-6 in lung epithelial cells. Pneumologie. 2025;79:134\u201340. https:\/\/doi.org\/10.1055\/a-2372-3632.","journal-title":"Pneumologie"},{"key":"915_CR71","doi-asserted-by":"publisher","first-page":"1021928","DOI":"10.3389\/fimmu.2022.1021928","volume":"13","author":"S Shahbaz","year":"2022","unstructured":"Shahbaz S, Oyegbami O, Saito S, Osman M, Sligl W, Elahi S. Differential effects of age, sex and dexamethasone therapy on ACE2\/TMPRSS2 expression and susceptibility to SARS-CoV-2 infection. Front Immunol. 2022;13:1021928. https:\/\/doi.org\/10.3389\/fimmu.2022.1021928.","journal-title":"Front Immunol"},{"key":"915_CR72","doi-asserted-by":"publisher","first-page":"162","DOI":"10.5152\/eurjrheum.2020.20048","volume":"8","author":"E Zanatta","year":"2021","unstructured":"Zanatta E, Codullo V, Allanore Y. Scleroderma renal crisis: case reports and update on critical issues. Eur J Rheumatol. 2021;8:162\u20137. https:\/\/doi.org\/10.5152\/eurjrheum.2020.20048.","journal-title":"Eur J Rheumatol"},{"key":"915_CR73","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1093\/rheumatology\/kead699","volume":"64","author":"A Collet","year":"2025","unstructured":"Collet A, Sanges S, Ghulam A, Genin M, Soudan B, Sobanski V, et al. Steroid hormones in systemic sclerosis: associations with disease characteristics and modifications during scleroderma renal crisis. Rheumatology (Oxford). 2025;64:283\u201395. https:\/\/doi.org\/10.1093\/rheumatology\/kead699.","journal-title":"Rheumatology (Oxford)"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-026-00915-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43440-026-00915-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-026-00915-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T20:02:01Z","timestamp":1791921721000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43440-026-00915-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,13]]},"references-count":73,"alternative-id":["915"],"URL":"https:\/\/doi.org\/10.1007\/s43440-026-00915-w","relation":{},"ISSN":["1734-1140","2299-5684"],"issn-type":[{"value":"1734-1140","type":"print"},{"value":"2299-5684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,13]]},"assertion":[{"value":"27 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"No AI was used to generate scientific content or conclusions. AI tools were used solely for language and formatting assistance.","order":1,"name":"Ethics","label":"AI usage","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}